Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Multi-modal Spatial Genomics in the Mouse and Human Brains - Summary the Major Goal of This Project Is to Build Upon Our Existing Expertise and Platform to Develop Spatial Multi-omics Tools in Human Brains. at Spatial Genomics, We Are Commercializing the Sequential Fluorescence in Situ Hybridization (seqfish) Technology (eng Et Al, 2019) That Allows Thousands of Genes to Be Imaged Directly in Brain Samples. We Have Developed Extensive Experience Working With Mouse and Human Brains With Our Seqfish Technology. Spatial Genomics Methods Have the Potential to Identify Novel Cell Types, Reveal Spatial Organization of Groups of Cells and Subcellular Patterns, and Elucidate Signaling Interactions Between Neighboring Cells in the Brain. Identifying the Spatial Organization of the Human Brain at Cellular Resolution From Single Cell Gene Expression Profiles Is Essential to Understanding Neuronal Circuits and Interactions Between Neurons and Glia.
Committed
$2.7 Million
Paid out
$2.6M
97%
Committed, not yet paid
$73.7K
3%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…